Garda Capital Partners’s Bristol-Myers Squibb BMY Stock Holding History

Garda Capital Partners’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-7,300	Closed	-$338K	–	80
2025 Q2	$338K	Buy	7,300 +100	+1%	+$4.91K	0.01%	496
2025 Q1	$439K	Buy	+7,200	New	+$420K	0.01%	546
2023 Q2	–	Sell	-37,500	Closed	-$2.6M	–	351
2023 Q1	$2.6M	Hold	37,500	–	–	0.13%	134
2022 Q4	$2.7M	Buy	+37,500	New	+$2.83M	0.15%	181

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Garda Capital Partners's BMY Position: Q2 2023 in Review

Garda Capital Partners sold out of Bristol-Myers Squibb (BMY) in Q2 2023, closing a stake of 12,393 shares — an estimated $859K sold.

Garda Capital Partners first reported a position in BMY in Q1 2023 and held it in 1 quarter. The position peaked at $859K in Q1 2023. 2,480 funds tracked by Wall St. Rank hold BMY as of Q2 2023.

Garda Capital Partners reported no remaining Bristol-Myers Squibb position as of Q2 2023 after selling out during the quarter.
Garda Capital Partners sold 12,393 Bristol-Myers Squibb shares in Q2 2023, an estimated $859K.
Garda Capital Partners first reported a position in Bristol-Myers Squibb in Q1 2023 and held it in 1 quarter.
Garda Capital Partners's Bristol-Myers Squibb position peaked at $859K in Q1 2023.
2,480 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2023.

Based on Garda Capital Partners's 13F filing for Q2 2023, filed 14 Aug 2023.